148 related articles for article (PubMed ID: 26831417)
1. Is CXCL10/CXCR3 axis overexpression a better indicator of leprosy type 1 reaction than inducible nitric oxide synthase?
Sharma I; Singh A; Mishra AK; Singh LC; Ramesh V; Saxena S
Indian J Med Res; 2015 Dec; 142(6):681-9. PubMed ID: 26831417
[TBL] [Abstract][Full Text] [Related]
2. Cytokine and protein markers of leprosy reactions in skin and nerves: baseline results for the North Indian INFIR cohort.
Lockwood DN; Suneetha L; Sagili KD; Chaduvula MV; Mohammed I; van Brakel W; Smith WC; Nicholls P; Suneetha S
PLoS Negl Trop Dis; 2011 Dec; 5(12):e1327. PubMed ID: 22180790
[TBL] [Abstract][Full Text] [Related]
3. Increased CXC ligand 10 levels and gene expression in type 1 leprosy reactions.
Scollard DM; Chaduvula MV; Martinez A; Fowlkes N; Nath I; Stryjewska BM; Kearney MT; Williams DL
Clin Vaccine Immunol; 2011 Jun; 18(6):947-53. PubMed ID: 21508169
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of chemokine receptor CXCR3 and its ligand CXCL10 in low-grade astrocytomas and glioblastoma multiforme: A tissue microarray-based comparison.
Sharma I; Siraj F; Sharma KC; Singh A
J Cancer Res Ther; 2016; 12(2):793-7. PubMed ID: 27461653
[TBL] [Abstract][Full Text] [Related]
5. Role of TEFFECTOR/MEMORY Cells, TBX21 Gene Expression and T-Cell Homing Receptor on Type 1 Reaction in Borderline Lepromatous Leprosy Patients.
Dos Santos LN; da Silva PH; Alvim IM; Nery JA; Lara FA; Sarno EN; Esquenazi D
PLoS One; 2016; 11(10):e0164543. PubMed ID: 27764137
[TBL] [Abstract][Full Text] [Related]
6. In situ T regulatory cells and Th17 cytokines in paired samples of leprosy type 1 and type 2 reactions.
Costa MB; Hungria EM; Freitas AA; Sousa ALOM; Jampietro J; Soares FA; Stefani MMA
PLoS One; 2018; 13(6):e0196853. PubMed ID: 29883464
[TBL] [Abstract][Full Text] [Related]
7. Potential plasma markers of Type 1 and Type 2 leprosy reactions: a preliminary report.
Stefani MM; Guerra JG; Sousa AL; Costa MB; Oliveira ML; Martelli CT; Scollard DM
BMC Infect Dis; 2009 May; 9():75. PubMed ID: 19473542
[TBL] [Abstract][Full Text] [Related]
8. Cortisol and proinflammatory cytokine profiles in type 1 (reversal) reactions of leprosy.
Chaitanya VS; Lavania M; Nigam A; Turankar RP; Singh I; Horo I; Sengupta U; Jadhav RS
Immunol Lett; 2013; 156(1-2):159-67. PubMed ID: 24189521
[TBL] [Abstract][Full Text] [Related]
9.
Das M; David D; Horo I; Van Hooij A; Tió-Coma M; Geluk A; Vedithi SC
Front Microbiol; 2023; 14():1113318. PubMed ID: 37051521
[TBL] [Abstract][Full Text] [Related]
10. Clinical and histopathological correlation in the classification of leprosy.
Bhatia AS; Katoch K; Narayanan RB; Ramu G; Mukherjee A; Lavania RK
Int J Lepr Other Mycobact Dis; 1993 Sep; 61(3):433-8. PubMed ID: 8228443
[TBL] [Abstract][Full Text] [Related]
11. Correlation of Clinico-pathological Classification of Hansen's Disease in a South Indian City.
Lobo AC; Pai RR; Gautam K; Kuruvila M
Indian J Lepr; 2014; 86(4):147-54. PubMed ID: 26411247
[TBL] [Abstract][Full Text] [Related]
12. Potential of AKR1B10 as a Biomarker and Therapeutic Target in Type 2 Leprosy Reaction.
Soares CT; Fachin LRV; Trombone APF; Rosa PS; Ghidella CC; Belone AFF
Front Med (Lausanne); 2018; 5():263. PubMed ID: 30320113
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of CXCR3 and its ligands in patients with vitiligo and CXCL10 as a potential clinical marker for vitiligo.
Wang XX; Wang QQ; Wu JQ; Jiang M; Chen L; Zhang CF; Xiang LH
Br J Dermatol; 2016 Jun; 174(6):1318-26. PubMed ID: 26801009
[TBL] [Abstract][Full Text] [Related]
14. The role of CXCR3 and its ligands expression in Brucellar spondylitis.
Hu X; Shang X; Wang L; Fan J; Wang Y; Lv J; Nazierhan S; Wang H; Wang J; Ma X
BMC Immunol; 2020 Nov; 21(1):59. PubMed ID: 33208100
[TBL] [Abstract][Full Text] [Related]
15. Association of viable Mycobacterium leprae with Type 1 reaction in leprosy.
Save MP; Dighe AR; Natrajan M; Shetty VP
Lepr Rev; 2016 Mar; 87(1):78-92. PubMed ID: 27255061
[TBL] [Abstract][Full Text] [Related]
16. CXCL10 can inhibit endothelial cell proliferation independently of CXCR3.
Campanella GS; Colvin RA; Luster AD
PLoS One; 2010 Sep; 5(9):e12700. PubMed ID: 20856926
[TBL] [Abstract][Full Text] [Related]
17. The histological diagnosis of leprosy type 1 reactions: identification of key variables and an analysis of the process of histological diagnosis.
Lockwood DN; Lucas SB; Desikan KV; Ebenezer G; Suneetha S; Nicholls P
J Clin Pathol; 2008 May; 61(5):595-600. PubMed ID: 18326022
[TBL] [Abstract][Full Text] [Related]
18. Mast cell heterogeneity and anti-inflammatory annexin A1 expression in leprosy skin lesions.
Costa MB; Mimura KKO; Freitas AA; Hungria EM; Sousa ALOM; Oliani SM; Stefani MMA
Microb Pathog; 2018 May; 118():277-284. PubMed ID: 29605649
[TBL] [Abstract][Full Text] [Related]
19. Comparing the clinical and histological diagnosis of leprosy and leprosy reactions in the INFIR cohort of Indian patients with multibacillary leprosy.
Lockwood DN; Nicholls P; Smith WC; Das L; Barkataki P; van Brakel W; Suneetha S
PLoS Negl Trop Dis; 2012; 6(6):e1702. PubMed ID: 22745841
[TBL] [Abstract][Full Text] [Related]
20. T regulatory cells and plasmocytoid dentritic cells in hansen disease: a new insight into pathogenesis?
Massone C; Nunzi E; Ribeiro-Rodrigues R; Talhari C; Talhari S; Schettini APM; Parente JNT; Brunasso AM; Puntoni M; Clapasson A; Noto S; Cerroni L
Am J Dermatopathol; 2010 May; 32(3):251-256. PubMed ID: 20075708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
